Kennedy disease

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Status:
Recruiting
Last Changed:
Jul 25, 2018
First Changed:
Jul 16, 2015
Disease(s):
Prostate Cancer
Intervention(s):
LY2452473Placebo
Study of BYL719 (Alpelisib) in Combination With Androgen Receptor Inhibitor (Enzalutamide) in Patients With Androgen Receptor (AR)-Positive and PTEN Positive Metastatic Breast Cancer
Status:
Not yet recruiting
Last Changed:
Jan 28, 2019
First Changed:
Jul 2, 2017
Disease(s):
Malignant Neoplasm of Breast
Intervention(s):
AlpelisibEnzalutamide
Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
Status:
Active, not recruiting
Last Changed:
Nov 15, 2018
First Changed:
Nov 4, 2013
Disease(s):
Advanced Epithelial Ovarian
Intervention(s):
Enzalutamide

Connect. Empower. Inspire.